UK markets closed
  • FTSE 100

    7,589.66
    +26.11 (+0.35%)
     
  • FTSE 250

    22,655.02
    +2.31 (+0.01%)
     
  • AIM

    1,149.49
    -4.71 (-0.41%)
     
  • GBP/EUR

    1.2010
    +0.0008 (+0.07%)
     
  • GBP/USD

    1.3628
    +0.0029 (+0.22%)
     
  • BTC-GBP

    30,937.64
    +232.55 (+0.76%)
     
  • CMC Crypto 200

    999.60
    +4.85 (+0.49%)
     
  • S&P 500

    4,586.46
    +9.35 (+0.20%)
     
  • DOW

    35,453.93
    +85.46 (+0.24%)
     
  • CRUDE OIL

    87.84
    +2.41 (+2.82%)
     
  • GOLD FUTURES

    1,840.70
    +28.30 (+1.56%)
     
  • NIKKEI 225

    27,467.23
    -790.02 (-2.80%)
     
  • HANG SENG

    24,127.85
    +15.07 (+0.06%)
     
  • DAX

    15,809.72
    +37.16 (+0.24%)
     
  • CAC 40

    7,172.98
    +39.15 (+0.55%)
     

Harvard MedTech to Discuss New Approaches to Pain Management for Injured Workers During Panel Presentation at Worker’s Compensation Institute Conference

·3-min read

Leveraging innovative technologies, including virtual reality, offers new solutions for addressing chronic pain and eliminates risks associated with opioid use

LAS VEGAS, November 30, 2021--(BUSINESS WIRE)--Harvard MedTech, a breakthrough digital health company, will participate in a panel presentation highlighting new approaches to pain management, including virtual reality technology and spinal cord stimulation, at the Worker’s Compensation Institute conference in Orlando, Florida, on Tuesday, Dec. 14, 2021, at 1:00 PM.

The session, titled "Spinal Cord Stimulation And Virtual Reality Treat Pain Without Opioids," will feature Harvard MedTech Advisory Board Member, Mark Pew, along with Miguel D. Attias, M.D., from Tampa Pain Relief Centers, and Navdeep Jassal, M.D., from the Spine & Pain Institute of Florida, and will be moderated by Miguel de la Garza, M.D., DABA, DAPM, from Comprehensive Pain Management Partners. Panelists will discuss two novel therapies that offer solutions for injured workers suffering with chronic pain that remove the risks associated with opioids: spinal cord stimulation and virtual reality.

Pew will explain how virtual reality combined with behavioral therapy has the ability to build new neural pathways, essentially retraining the brain’s response to pain. He will also outline best practices and present case studies that demonstrate the program can be a successful alternative to opioids for managing pain.

"Leveraging new technologies to manage chronic pain eliminates the risks associated with complex surgeries and ongoing medication usage," said Pew. "I look forward to sharing how Harvard MedTech’s Vx Therapy takes a holistic approach to pain management, combining the biopsychosocial model with virtual reality therapy. This novel treatment is resulting in positive clinical outcomes that come from focusing on the injured worker as a human being, not just as a claimant."

Harvard MedTech’s Vx Therapy is based on new science about how the brain works. The VR therapy is used in the home, and is coupled with personalized behavioral health intervention strategies that teach more skills to permanently lower pain and discomfort that contribute to depression and sleep disorders. The patient uses virtual reality technology to have positive, engaging experiences that reduce the sensation of pain while the brain builds new neural pathways. With the application of digital health, Vx Therapy is a scalable solution for employers, carriers and risk managers to manage patient populations and contain costs.

The conference takes place Dec. 12-15 at Orlando World Center Marriott. For more information, contact Pat McCutcheon, PMcCutcheon@harvardmedtech.com, 516-946-7938.

About Harvard MedTech

Harvard MedTech is a breakthrough digital health company that is tapping the new science of how the brain works, combining specially designed virtual reality experiences, psychosocial support, digital engagement and proprietary AI algorithms to retrain neural pathways and alleviate the effects of trauma, including pain, PTSD, anxiety, depression and sleep disorders. The company’s Vx Therapy model is the first to comprehensively integrate this unique combination of digital technologies with behavioral health interventions, in a virtual application that moves the points of care to the patient’s home. This virtual engagement drives high compliance, patient satisfaction and optimal outcomes. It also allows the solution to be affordable and scalable at a population health level. This non-invasive and non-pharmacological approach also provides data that is trackable for a clear assess of its value to patient and health care providers. Visit www.harvardmedtech.com for more information.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211130006011/en/

Contacts

Media Contact
Joy Scott
Scott Public Relations
818-610-0270
Joy@scottpublicrelations.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting